Abiopharma

New Form 8-K - Ocugen, Inc. Filed: 2025-05-09 AccNo: 0001628280-25-024095 Size: 5 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits